The Life Sciences Innovative Manufacturing Fund (LSIMF)

The Life Sciences Innovative Manufacturing Fund (LSIMF) is a capital grants fund which aims to build resilience for future health emergencies and capitalise on the UK's world-leading research and development capabilities. The fund will enhance and accelerate affordable access to mature, new and emerging Life Sciences products for both pandemic and non-pandemic scenarios. LSIMF will provide up to £520 million in capital grants for investment in the manufacture of human medicines and medical technology (including diagnostics, and MedTech products). Projects with a total cost of at least £8 million are eligible to apply. The maximum intervention rate is 25%, with the typical intervention rate being 10-20% of total project costs. The fund is open to UK registered businesses for manufacturing projects that increase UK health resilience and create economic opportunity through high-wage, high-skilled jobs.